We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

90 hedge funds and large institutions have $147M invested in Applied Genetic Technologies Corporation in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 43 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 19

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

2% more funds holding

Funds holding: 8890 (+2)

34% less capital invested

Capital invested by funds: $223M → $147M (-$76M)

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

Holders
90
Holders Change
+2
Holders Change %
+2.27%
% of All Funds
2.4%
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
13
Increased
43
Reduced
19
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$21.5M -$3.26M -222,469 -13%
NI
2
Numeric Investors
Massachusetts
$9.71M +$6.86M +467,610 +206%
Jennison Associates
3
Jennison Associates
New York
$9.57M +$100K +6,830 +1%
PA
4
Perceptive Advisors
New York
$9.1M -$3.09M -210,922 -24%
EMFAT
5
Emerald Mutual Fund Advisers Trust
Pennsylvania
$6.65M +$3.97M +270,387 +132%
BFA
6
BlackRock Fund Advisors
California
$6.47M +$243K +16,541 +4%
PI
7
Putnam Investments
Massachusetts
$5.8M +$14.7K +999 +0.2%
Vanguard Group
8
Vanguard Group
Pennsylvania
$5.79M +$839K +57,183 +16%
EA
9
Emerald Advisers
Pennsylvania
$4.22M +$1.72M +117,254 +64%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$4.14M +$3.05M +207,776 +234%
EAM
11
Eventide Asset Management
Massachusetts
$3.9M
RCM
12
RA Capital Management
Massachusetts
$3.3M
AGA
13
Altrinsic Global Advisors
Connecticut
$2.78M
PAM
14
Panagora Asset Management
Massachusetts
$2.74M +$982K +66,952 +52%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$2.66M
State Street
16
State Street
Massachusetts
$2.46M +$909K +61,985 +54%
TC
17
TFS Capital
Pennsylvania
$2.36M -$1.82M -124,112 -42%
DCM
18
DAFNA Capital Management
California
$2.34M +$147K +10,000 +6%
OAM
19
Oxford Asset Management
United Kingdom
$2.32M +$2.44M +166,088 New
JP Morgan Chase
20
JP Morgan Chase
New York
$2.29M -$160K -10,923 -6%
BIT
21
BlackRock Institutional Trust
California
$2.27M +$290K +19,736 +14%
VAM
22
Visium Asset Management
New York
$2.16M -$4.7M -320,249 -67%
Invesco
23
Invesco
Georgia
$2.09M +$349K +23,800 +19%
Millennium Management
24
Millennium Management
New York
$1.83M -$766K -52,199 -28%
BIM
25
Bogle Investment Management
Massachusetts
$1.45M -$395K -26,953 -21%

AGTC Hedge Fund Activity: Q1 2016 in Review

90 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q1 2016, worth a combined $147M — down 34% from $223M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new AGTC positions and 11 closed out — a net gain of 2 holders — while 43 added to existing stakes and 19 trimmed.

The largest buyer was Numeric Investors, adding an estimated $6.86M. The largest seller was Point72 Asset Management, cutting an estimated $9.42M.

  • 90 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q1 2016, up from 88 in Q4 2015.
  • Funds reported $147M of Applied Genetic Technologies Corporation stock for Q1 2016, down 34% quarter-over-quarter.
  • 13 funds opened new Applied Genetic Technologies Corporation positions in Q1 2016 and 11 closed out, a net change of +2 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q1 2016 was Numeric Investors, an estimated $6.86M added.
  • The largest Applied Genetic Technologies Corporation seller in Q1 2016 was Point72 Asset Management, an estimated $9.42M sold.

Based on aggregated 13F filings for Q1 2016.